Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      AstraZeneca Farxiga approved in US to reduce heart failure risk in Type-2 diabetes

      AstraZeneca Farxiga approved in US to reduce heart failure risk in Type-2 diabetes

      Medical Dialogues Bureau23 Oct 2019 9:30 AM IST
      Farxiga is also under regulatory review in China with a decision anticipated in the first half of 2020, AstraZeneca said in a release.New Delhi:...
      CDSCO directs drug regulators to strictly monitor end-use of dual-use APIs

      CDSCO directs drug regulators to strictly monitor end-use of dual-use APIs

      Medical Dialogues Bureau22 Oct 2019 5:32 PM IST
      New Delhi: Through a recent Office Memorandum, Central Drugs Standard Control Organisation (CDSCO) has directed drug regulators to strictly monitor...
      GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

      GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

      Medical Dialogues Bureau22 Oct 2019 10:00 AM IST
      The sale of GSK's anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, to the Denmark-based biotechnology...
      Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

      Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

      Medical Dialogues Bureau22 Oct 2019 9:50 AM IST
      Roche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
      Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

      Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

      Medical Dialogues Bureau22 Oct 2019 9:45 AM IST
      The minister contended that Hyderabad Pharma City is the "world's largest integrated pharma park" to promote domestic manufacturing of pharmaceuticals...
      Teva Pharma, 3 others reach tentative deal to settle opioid lawsuit

      Teva Pharma, 3 others reach tentative deal to settle opioid lawsuit

      Medical Dialogues Bureau22 Oct 2019 9:00 AM IST
      New Delhi: The US's three dominant drug distributors and a big drugmaker have reached a tentative deal to settle a lawsuit related to the opioid...
      Parliamentary panel to now examine regulation, control of medical devices

      Parliamentary panel to now examine regulation, control of medical devices

      Medical Dialogues Bureau21 Oct 2019 2:20 PM IST
      New Delhi: A parliamentary panel has decided to examine regulation and control of medical devices in the country to ensure that they meet certain...
      Johnson and Johnson wins EMA vote for depression drug Spravato

      Johnson and Johnson wins EMA vote for depression drug Spravato

      Medical Dialogues Bureau21 Oct 2019 10:15 AM IST
      J&J has said that over 2,000 centres in the U.S. have been certified to administer Spravato, which has been touted as an asset with blockbuster...
      Sanofi pulls popular heartburn drug Zantac in US, Canada

      Sanofi pulls popular heartburn drug Zantac in US, Canada

      Medical Dialogues Bureau21 Oct 2019 9:30 AM IST
      In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and...
      Landmark trial expected after opioid settlement talks fail

      Landmark trial expected after opioid settlement talks fail

      Medical Dialogues Bureau21 Oct 2019 9:00 AM IST
      New Delhi: A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on...
      AstraZeneca, Daiichi Trastuzumab deruxtecan gets USFDA priority review for treating breast cancer

      AstraZeneca, Daiichi Trastuzumab deruxtecan gets USFDA priority review for treating breast cancer

      Medical Dialogues Bureau20 Oct 2019 9:50 AM IST
      New Delhi: AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) recently announced that the US Food and Drug Administration (FDA) has...
      Bristol Myers Squibb-Pfizer Alliance in collaboration with Fitbit to take on Apple Watch

      Bristol Myers Squibb-Pfizer Alliance in collaboration with Fitbit to take on Apple Watch

      Medical Dialogues Bureau20 Oct 2019 9:45 AM IST
      Under Thursday's deal, the company's devices will carry software that will help detect atrial fibrillation - the most common type of irregular...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok